Apnimed, Inc.
Pharmaceuticals · CAMBRIDGE, MA
PharmaceuticalsSEC Form D
Apnimed, Inc. filed a Form D with the U.S. Securities and Exchange Commission on March 27, 2026, reporting $24,999,994 raised.
Incorporated in Delaware and based in CAMBRIDGE, MA, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that Apnimed, Inc. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- Lawrence G. MillerExecutive Officer · Director
- Barry WohlExecutive Officer
- Dennis MolnarExecutive Officer
- Joseph C. AvelloneDirector
- Francois BeaubienDirector
- Isaac ChengDirector
- Chris C. DimitropoulosDirector
- Paul FonteyneDirector
- Kevin C. LindDirector
- Gary SenderDirector
- Ramzi BenamarExecutive Officer
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised